Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Clinical Biochemistry,Biochemistry,Analytical Chemistry
Reference19 articles.
1. Gray EZ, Charles WF, Douglas KH, Steven JB, Michael RB (1997) Development of the clinical candidate’s eperezolid and linezolid. Expert Opin Investig Drugs 6(2):151–158. https://doi.org/10.1517/13543784.6.2.1511
2. Kanafani ZA, Corey GR (2012) Tedizolid (TR-701): a new Oxazolidinone with enhanced potency. Expert Opin Investig Drugs 21(4):515–522. https://doi.org/10.1517/13543784.2012.660250
3. Shuan W, Xiaopan G, Weijie Z, Fengmin H, Guanglu J, Lingling D, Liping Z, Fen W, Xia Y, Hairong H (2020) In Vitro efficacy comparison of linezolid, tedizolid, sutezolid and delpazolid against rapid growing mycobacteria isolated in Beijing, China. BioRxiv. https://doi.org/10.1101/2020.06.25.172742
4. Patil VJ, Hangarge RV, Munshi AB, Loganathan V, Trivedi BK (2012) Process for the preparation of phosphoric acid mono- (l-{4- [(s) -5- (acetylaminomethyl) - 2 - oxo - oxazolidin- 3 - yl] - 2, 6 - difluorophenyl} - 4 -methoxymethylpiperidin- 4 - yl) ester. US Patent WO 2012059823 A1
5. Patil VJ, Patel MV, Trivedi BK, Dekhane DV, Shaikh, MU, Chugh Y, Chavan RP, Jafri MA (2012) Substituted piperidino phenyloxazolidinones. US Patent US8288416 B2
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献